Plasma

Improving patient safety: preventing a harmful side effect of IVIg treatment


Friday, April 09, 2021
Our research is improving patient safety for those who need intravenous immune globulin (IVIg), a drug used to treat autoimmune diseases. By increasing our understanding of an unexpected, potentially life-threatening side effect of IVIg therapy, our studies can help doctors better predict which patients are most at risk and take steps to protect them.

The Canadian Blood Services Lifetime Achievement Award 2021: Nominations now open


Tuesday, April 06, 2021
The Canadian Blood Services Lifetime Achievement Award recognizes individuals whose landmark contributions are both extraordinary and world class in the field of transfusion or transplantation medicine, stem cell or cord blood research in Canada and/or abroad.

2020: The year no one expected - Challenges researchers face during a global pandemic


Thursday, April 01, 2021
Sarah Longo’s personal and engaging story describing the challenges she faced starting a new research position in the middle of the pandemic was awarded runner up in this year’s Lay Science Writing Competition.

Lost in lab: deciphering blood immune cells to fight COVID-19


Tuesday, March 23, 2021
We are delighted to publish the entries that were awarded joint first place in this year’s Lay Science Writing Competition. Read on for Melina Messing’s sobering but ultimately hopeful entry describing her experiences as a immunology researcher during the pandemic.

Challenges 2020: Lay science writing winners announced


Thursday, March 11, 2021
The Centre for Innovation is delighted to announce the winners of the 2020-2021 Canadian Blood Services Lay Science Writing Competition. Read on to find out who won!

Why getting a COVID-19 vaccine shouldn’t stop you from donating blood


Thursday, March 04, 2021
You may be aware that there’s no deferral for blood donors after they receive a vaccine against COVID-19. But you might be wondering how the blood operators made this decision. Canadian Blood Services' medical director for donor and clinical services, Dr. Mindy Goldman, answers questions.

Understanding the politics of clinical trials in a pandemic


Thursday, February 25, 2021
A pandemic, and a possible blood-derived treatment, means blood operators like Canadian Blood Services have found themselves playing a unique role in national and international clinical trials. Canadian Blood Services social scientist, Dr. Kelly Holloway, and her collaborators, were recently awarded funding to understand the role and experience of blood operators as they navigate this new landscape.

IVIg alternative for surgery patients with bleeding disorder


Tuesday, February 09, 2021
With an anticipated global shortage of immune globulin products, finding alternatives to IVIg can help improve availability of a drug in high demand. A recent study shows that eltrombopag, an oral medication that stimulates the production of platelets, is an effective alternative to IVIg for patients with immune thrombocytopenia who need surgery.

Call for applications! Research funding opportunities now open


Friday, January 29, 2021
The Intramural Research Grant Program, one of the Centre for Innovation’s most responsive and impactful research funding programs, and the Kenneth J. Fyke Program, which supports health services and policy research, are both open for applications.

Chief scientist Dr. Dana Devine takes on directorship at Centre for Blood Research


Tuesday, January 19, 2021
Dr. Devine will bring roles together to bridge discoveries into better care